Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
about
In vivo bio-imaging using chlorotoxin-based conjugatesStress Response Leading to Resistance in Glioblastoma-The Need for Innovative Radiotherapy (iRT) ConceptsTo what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?Through the patient's eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma.Confocal laser endomicroscopy for diagnosis and histomorphologic imaging of brain tumors in vivo5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature.Surgical management of high-grade glioma: a standard of care.A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and scienceDGKI methylation status modulates the prognostic value of MGMT in glioblastoma patients treated with combined radio-chemotherapy with temozolomide.Use of language mapping to aid in resection of gliomas in eloquent brain regions.5-Aminolevulinic acid-derived tumor fluorescence: the diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging.Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomasConfocal laser endomicroscopy in neurosurgery: a new technique with much potential.Modulation of PPIX synthesis and accumulation in various normal and glioma cell lines by modification of the cellular signaling and temperature.Clinical experience of glioma surgery using "tailed bullet": overcoming the limitations of conventional neuro-navigation guided surgeryAdult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registriesFluorescence guided resection and glioblastoma in 2015: A review.TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro.Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection.High levels of cellular proliferation predict pseudoprogression in glioblastoma patientsPrognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.Rapid regression of glioblastoma following carmustine wafer implantation: A case reportCan the prognosis of individual patients with glioblastoma be predicted using an online calculator?Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review.Time trends in glioblastoma multiforme survival: the role of temozolomide.Selective accumulation of hematoporphyrin derivative in glioma through proton-coupled folate transporter SLC46A1.Surgeon volume and 30 day mortality for brain tumours in England.Surgical debulking promotes recruitment of macrophages and triggers glioblastoma phagocytosis in combination with CD47 blocking immunotherapy.Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience.Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.Emerging new trends in neurosurgical technologies.The continuing evolution: biology and treatment of brain tumors.The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.Genetic Factors Affecting Intraoperative 5-aminolevulinic Acid-induced Fluorescence of Diffuse Gliomas.The brain tissue response to surgical injury and its possible contribution to glioma recurrence.Annexin 2A sustains glioblastoma cell dissemination and proliferation.Various shades of red-a systematic analysis of qualitative estimation of ALA-derived fluorescence in neurosurgery.
P2860
Q24595399-FD2BAE32-E3F6-4CB6-80F4-AE59D0EA8AD6Q26771706-19DFAA1E-366B-4F8C-B0A8-8E630B2BBEA4Q27028189-4353C40E-9E58-449D-9442-4A88EC9A0FEBQ30363967-EBF727DD-4FA8-4009-86DB-903A960D76C7Q30465403-99BAD7A6-432B-4649-A9BE-1ADDDEFCA9C2Q30814718-B90E75CD-20E9-4133-8ADB-0736DB2427EAQ30838365-3FC33399-1EA4-4EE8-9B73-FFB7C5A2BEBAQ33668084-D74E0A91-16E3-4BF8-9334-969002E915B9Q33746514-F0A05332-7031-4690-8D5C-BB3D801C6338Q34215037-BAE29E8A-1756-4871-AF93-405CFEB99325Q34322847-7CF34823-0239-44ED-842A-AF7F980C9D16Q34387771-CCE9E220-EB9D-4DAD-A63F-F83D09583C70Q34414528-C780B6D2-AFAE-47E8-8787-171186950A48Q34975507-1A450F03-1741-4ACC-923B-2BE03C98968AQ34987635-131C6261-1EE2-4D29-A483-3E02177A43D5Q35086049-D5DE02BB-3301-4A4B-A557-FABB8DA51424Q35605776-3098EC6D-DDBB-44C5-89A4-292B8D4E8D86Q35623174-57A54308-9901-40EA-A3D1-7A0685C15EF6Q36197395-4F9FB461-4CF1-40A1-9C9A-2D83DC3E8E3DQ36367414-E632CD61-4DD6-4155-A1A7-E5F239437F4FQ36645695-F5FF0D61-8F16-4038-AA16-4E7F953F1EDCQ36969519-98847541-51ED-40F1-BE72-B4A3152E2591Q37001342-64498F48-6E1A-4644-B2CC-8FA0AF51D12CQ37021532-D05EE925-DD86-4592-817F-CED2493315B2Q37026387-3866BCDA-CF0B-4058-9609-F91D4D99035EQ37312701-2AF0E03C-7C0C-452D-B232-2474FC390C6EQ37440350-EC8F30BC-0B93-48EA-B4E6-B39FF47F5552Q37457216-7B9B952F-46E6-4878-8C88-31DA68DBCEB6Q37707063-CC127E04-EBCB-45C6-9099-AB85BCF4AA5CQ38010801-80E3AC9A-730F-4AB6-AB57-D3879CD8F6FDQ38021521-96E88F53-7646-47ED-9C27-16D1F8689326Q38093776-CB2E284D-20A6-481B-A5A6-96EA733756E2Q38111449-A35331C9-F470-4880-95C2-6CB8F7415BABQ38196751-29CB7C61-591F-4DB7-A1BE-D7252EE44F19Q38230516-E7FF4601-758C-4479-ACDC-F1E3D362D996Q38546470-01430277-71E3-430E-B1D8-50BB6A143DC6Q38663395-38A0C026-996C-45AB-A590-BE1C50A95E5AQ38767957-05052E90-7994-4947-9998-629CAA26B975Q38840667-C2753ABB-F07A-45DF-9240-8E596E6B5E4DQ38844368-A3762FF4-0CF5-413C-B725-56382BEEB874
P2860
Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cytoreductive surgery of gliob ...... rguments in an old discussion.
@en
Cytoreductive surgery of gliob ...... rguments in an old discussion.
@nl
type
label
Cytoreductive surgery of gliob ...... rguments in an old discussion.
@en
Cytoreductive surgery of gliob ...... rguments in an old discussion.
@nl
prefLabel
Cytoreductive surgery of gliob ...... rguments in an old discussion.
@en
Cytoreductive surgery of gliob ...... rguments in an old discussion.
@nl
P2093
P2860
P1433
P1476
Cytoreductive surgery of gliob ...... rguments in an old discussion.
@en
P2093
Manfred Westphal
Martin J van den Bent
Walter Stummer
P2860
P2888
P304
P356
10.1007/S00701-011-1001-X
P577
2011-04-09T00:00:00Z